ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 109 filers reported holding ZIOPHARM ONCOLOGY INC in Q1 2023. The put-call ratio across all filers is 0.03 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $441 | -2.9% | 700 | 0.0% | 0.00% | – |
| Q4 2022 | $454 | -54.6% | 700 | 0.0% | 0.00% | – |
| Q3 2022 | $1,000 | 0.0% | 700 | 0.0% | 0.00% | – |
| Q2 2022 | $1,000 | – | 700 | 0.0% | 0.00% | – |
| Q1 2022 | $0 | -100.0% | 700 | 0.0% | 0.00% | – |
| Q4 2021 | $1,000 | 0.0% | 700 | 0.0% | 0.00% | – |
| Q3 2021 | $1,000 | -50.0% | 700 | 0.0% | 0.00% | – |
| Q2 2021 | $2,000 | -33.3% | 700 | 0.0% | 0.00% | -100.0% |
| Q1 2021 | $3,000 | 0.0% | 700 | -36.4% | 0.00% | 0.0% |
| Q4 2020 | $3,000 | 0.0% | 1,100 | -15.4% | 0.00% | 0.0% |
| Q3 2020 | $3,000 | -25.0% | 1,300 | 0.0% | 0.00% | -50.0% |
| Q2 2020 | $4,000 | +33.3% | 1,300 | 0.0% | 0.00% | +100.0% |
| Q1 2020 | $3,000 | -70.0% | 1,300 | -38.1% | 0.00% | -75.0% |
| Q4 2019 | $10,000 | +11.1% | 2,100 | +5.0% | 0.00% | 0.0% |
| Q3 2019 | $9,000 | -25.0% | 2,000 | 0.0% | 0.00% | -20.0% |
| Q2 2019 | $12,000 | +20.0% | 2,000 | -20.0% | 0.01% | +25.0% |
| Q1 2019 | $10,000 | +150.0% | 2,500 | +19.0% | 0.00% | +100.0% |
| Q4 2018 | $4,000 | -50.0% | 2,100 | -19.2% | 0.00% | -33.3% |
| Q3 2018 | $8,000 | -11.1% | 2,600 | -16.1% | 0.00% | -25.0% |
| Q2 2018 | $9,000 | -47.1% | 3,100 | -29.5% | 0.00% | -42.9% |
| Q1 2018 | $17,000 | -26.1% | 4,400 | -21.4% | 0.01% | -30.0% |
| Q4 2017 | $23,000 | -41.0% | 5,600 | -12.5% | 0.01% | -47.4% |
| Q3 2017 | $39,000 | -9.3% | 6,400 | -7.2% | 0.02% | -13.6% |
| Q2 2017 | $43,000 | -6.5% | 6,900 | -5.5% | 0.02% | -8.3% |
| Q1 2017 | $46,000 | +17.9% | 7,300 | 0.0% | 0.02% | +20.0% |
| Q4 2016 | $39,000 | -4.9% | 7,300 | 0.0% | 0.02% | -9.1% |
| Q3 2016 | $41,000 | +10.8% | 7,300 | +7.4% | 0.02% | +4.8% |
| Q2 2016 | $37,000 | -24.5% | 6,800 | +3.0% | 0.02% | -22.2% |
| Q1 2016 | $49,000 | +2.1% | 6,600 | +13.8% | 0.03% | 0.0% |
| Q4 2015 | $48,000 | -4.0% | 5,800 | +3.6% | 0.03% | -10.0% |
| Q3 2015 | $50,000 | -10.7% | 5,600 | +20.4% | 0.03% | -6.2% |
| Q2 2015 | $56,000 | +47.4% | 4,651 | +32.9% | 0.03% | +33.3% |
| Q1 2015 | $38,000 | – | 3,500 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 15,461,829 | $2,037,869 | 0.36% |
| MSD Partners, L.P. | 15,151,516 | $1,996,970 | 0.16% |
| MSD Partners, L.P. | 7,575,758 | $998,485 | 0.08% |
| MAGNOLIA CAPITAL ADVISORS LLC | 865,938 | $65,552 | 0.03% |
| Allred Capital Management, LLC | 253,000 | $33,345 | 0.02% |
| CHIRON CAPITAL MANAGEMENT, LLC | 77,023 | $10,152 | 0.01% |
| Boxer Capital, LLC | 1,100,000 | $144,980 | 0.01% |
| GSA CAPITAL PARTNERS LLP | 569,566 | $75 | 0.01% |
| Sugarloaf Wealth Management, LLC | 75,500 | $9,951 | 0.00% |
| Owen LaRue, LLC | 11,825 | $1,559 | 0.00% |